Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Vaccines' Protection Over Time and the Need for Booster Doses; a Systematic Review.
Omid Dadras, SeyedAhmad SeyedAlinaghi, Amirali Karimi, et al.
PubMed (2022) Vol. 10, Iss. 1, pp. e53-e53
Closed Access | Times Cited: 18

Showing 18 citing articles:

Determinants of COVID-19 vaccine fatigue
Tanja Stamm, Julia Partheymüller, Erika Mosor, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1164-1171
Open Access | Times Cited: 54
Antibody longevity and waning following COVID-19 vaccination in a 1-year longitudinal cohort in Bangladesh
Md. Ahsanul Haq, Anjan Kumar Roy, Razu Ahmed, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
Shiyao Xu, Jincheng Li, Hongyuan Wang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Comparing Antibody Responses to Homologous vs. Heterologous COVID-19 Vaccination: A Cross-Sectional Analysis in an Urban Bangladeshi Population
Kazi Istiaque Sanin, Mansura Khanam, Azizur Rahman Sharaque, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 67-67
Open Access
“At the End of the Day, the Decisions Were Ultimately Up to Them:” Collectivism and Community Care as Underliers of COVID-19 Vaccine Uptake Among Older Asian American Immigrants in the United States
Cindy Sousa, Isabel S. Lee
Journal of Community Practice (2025), pp. 1-20
Closed Access
Incidence of dynamic seroconversion in subjects received the first dose of the SARS-COV-2 vaccine (AstraZeneca, Moderna and Pfizer) in Kinshasa, Democratic Republic of Congo: prospective cohort study
Eric Kasongo Mukenge, Blaise Matondo Manzambi Sumbu, Aliocha Natuhoyila Nkodila, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding
Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review
SeyedAhmad SeyedAlinaghi, Mohsen Dashti, Arian Afzalian, et al.
Preventive Medicine Reports (2024) Vol. 44, pp. 102778-102778
Open Access | Times Cited: 1
Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico
María Elena Romero-Ibarguengoitia, Diego Rivera-Salinas, Riccardo Sarti, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 842-842
Open Access | Times Cited: 4
Vaccination with Tozimameran Induces T-Cell Activation, but Not Senescent or Exhaustive Alterations, in Kidney Transplant Recipients
Stamatia Stai, Γεώργιος Λιούλιος, Aliki Xochelli, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 877-877
Open Access
Rate, risk factors, and clinical outcomes of SARS-CoV-2 reinfection vs. primary infection in readmitted COVID-19 patients in Iran: a retrospective cohort study
Mohammadamin Shahrbaf, Yousef Alimohamadi, Reza Yousefi Arfaei, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
Antibody Response Following COVID-19 Vaccination in Malaysian Cancer Patients and Healthy Individuals
Chin Vern Song, Ros Suzanna Bustamam, Gin Gin Gan, et al.
Cureus (2024)
Open Access
Immunogenicity and safety of DS-5670d, an mRNA-based COVID-19 vaccine targeting omicron XBB.1.5: Results from a phase 3, randomized, active-controlled study in adults and children aged ≥12 years
Ami Kawamoto, Masaki Hashida, Katsuyasu Ishida, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Clinical advancements in mRNA vaccines against viral infections
Munazza Fatima, Pil‐Gu Park, Kee‐Jong Hong
Clinical Immunology (2024), pp. 110424-110424
Closed Access
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance
James Hollister, Cynthia Porter, Ryan Sprissler, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0306953-e0306953
Open Access
Analysis of articles in the Journal of Archives of Academic Emergency Medicine in 2022.
Somayeh Saghaei Dehkordi, Mehrnoosh Yazdanbakhsh
DOAJ (DOAJ: Directory of Open Access Journals) (2023) Vol. 11, Iss. 1, pp. e3-e3
Closed Access | Times Cited: 1
Personalized Feedback about COVID-19 Immunity Corrects Risk Misestimation and Motivates Booster Vaccinations
Alyssa Hannah Sinclair, Morgan Taylor, Stephen J. Beckett, et al.
(2023)
Open Access | Times Cited: 1
Associations between laboratory variables and clinical features in patients hospitalized with COVID-19 after non-mRNA vaccination in China: A cross-sectional study
Dan Zhu, Tie Wu, Yu Xiao, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18167-e18167
Open Access
Can Vaccination with Various Types of Vaccines Make Communities Safer against COVID-19?
SeyedAhmad SeyedAlinaghi, Pegah Mirzapour, Esmaeil Mehraeen
Infectious Disorders - Drug Targets (2023) Vol. 24, Iss. 3
Closed Access
Page 1

Scroll to top